215 related articles for article (PubMed ID: 22003207)
1. Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection.
Kok WL; Denney L; Benam K; Cole S; Clelland C; McMichael AJ; Ho LP
J Leukoc Biol; 2012 Mar; 91(3):357-68. PubMed ID: 22003207
[TBL] [Abstract][Full Text] [Related]
2. Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.
Paget C; Ivanov S; Fontaine J; Blanc F; Pichavant M; Renneson J; Bialecki E; Pothlichet J; Vendeville C; Barba-Spaeth G; Huerre MR; Faveeuw C; Si-Tahar M; Trottein F
J Immunol; 2011 May; 186(10):5590-602. PubMed ID: 21490153
[TBL] [Abstract][Full Text] [Related]
3. Activation of invariant NKT cells in early phase of experimental autoimmune encephalomyelitis results in differentiation of Ly6Chi inflammatory monocyte to M2 macrophages and improved outcome.
Denney L; Kok WL; Cole SL; Sanderson S; McMichael AJ; Ho LP
J Immunol; 2012 Jul; 189(2):551-7. PubMed ID: 22685310
[TBL] [Abstract][Full Text] [Related]
4. Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice.
Antunes I; Kassiotis G
J Virol; 2010 Dec; 84(24):12564-75. PubMed ID: 20943986
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Monocytes Drive Influenza A Virus-Mediated Lung Injury in Juvenile Mice.
Coates BM; Staricha KL; Koch CM; Cheng Y; Shumaker DK; Budinger GRS; Perlman H; Misharin AV; Ridge KM
J Immunol; 2018 Apr; 200(7):2391-2404. PubMed ID: 29445006
[TBL] [Abstract][Full Text] [Related]
6. Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection.
Barthelemy A; Ivanov S; Fontaine J; Soulard D; Bouabe H; Paget C; Faveeuw C; Trottein F
Mucosal Immunol; 2017 Mar; 10(2):460-469. PubMed ID: 27220813
[TBL] [Abstract][Full Text] [Related]
7. Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection.
Coulombe F; Fiola S; Akira S; Cormier Y; Gosselin J
PLoS One; 2012; 7(5):e36734. PubMed ID: 22590599
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the 4-1BB/4-1BBL pathway in control of monocyte numbers by invariant NKT cells.
Cole SL; Benam KH; McMichael AJ; Ho LP
J Immunol; 2014 Apr; 192(8):3898-907. PubMed ID: 24639347
[TBL] [Abstract][Full Text] [Related]
9. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality.
Lin KL; Suzuki Y; Nakano H; Ramsburg E; Gunn MD
J Immunol; 2008 Feb; 180(4):2562-72. PubMed ID: 18250467
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Regulatory T Cells in Nucleotide-Binding Oligomerization Domain 2 Response to Influenza Virus Infection.
Egarnes B; Gosselin J
Front Immunol; 2018; 9():132. PubMed ID: 29445379
[TBL] [Abstract][Full Text] [Related]
11. Editorial: NKT get the 'flu: NKT cells as (mostly) good guys in influenza; monocytic cells as double agents.
Exley MA
J Leukoc Biol; 2012 Mar; 91(3):349-52. PubMed ID: 22379073
[No Abstract] [Full Text] [Related]
12. Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection.
Ho LP; Denney L; Luhn K; Teoh D; Clelland C; McMichael AJ
Eur J Immunol; 2008 Jul; 38(7):1913-22. PubMed ID: 18521958
[TBL] [Abstract][Full Text] [Related]
13. Type I Interferon Induced Epigenetic Regulation of Macrophages Suppresses Innate and Adaptive Immunity in Acute Respiratory Viral Infection.
Kroetz DN; Allen RM; Schaller MA; Cavallaro C; Ito T; Kunkel SL
PLoS Pathog; 2015 Dec; 11(12):e1005338. PubMed ID: 26709698
[TBL] [Abstract][Full Text] [Related]
14. Activation of pulmonary invariant NKT cells leads to exacerbation of acute lung injury caused by LPS through local production of IFN-γ and TNF-α by Gr-1+ monocytes.
Aoyagi T; Yamamoto N; Hatta M; Tanno D; Miyazato A; Ishii K; Suzuki K; Nakayama T; Taniguchi M; Kunishima H; Hirakata Y; Kaku M; Kawakami K
Int Immunol; 2011 Feb; 23(2):97-108. PubMed ID: 21172897
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells.
Ishikawa H; Tanaka K; Kutsukake E; Fukui T; Sasaki H; Hata A; Noda S; Matsumoto T
Virology; 2010 Nov; 407(2):325-32. PubMed ID: 20855097
[TBL] [Abstract][Full Text] [Related]
16. Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection.
Latha K; Jamison KF; Watford WT
Front Immunol; 2021; 12():738490. PubMed ID: 34691044
[TBL] [Abstract][Full Text] [Related]
17. Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.
Mahmoud AB; Tu MM; Wight A; Zein HS; Rahim MM; Lee SH; Sekhon HS; Brown EG; Makrigiannis AP
PLoS Pathog; 2016 Feb; 12(2):e1005446. PubMed ID: 26928844
[TBL] [Abstract][Full Text] [Related]
18. Invariant NKT Cell-Mediated Modulation of ILC1s as a Tool for Mucosal Immune Intervention.
Trittel S; Vashist N; Ebensen T; Chambers BJ; Guzmán CA; Riese P
Front Immunol; 2019; 10():1849. PubMed ID: 31440243
[TBL] [Abstract][Full Text] [Related]
19. Invariant NKT cell response to dengue virus infection in human.
Matangkasombut P; Chan-In W; Opasawaschai A; Pongchaikul P; Tangthawornchaikul N; Vasanawathana S; Limpitikul W; Malasit P; Duangchinda T; Screaton G; Mongkolsapaya J
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2955. PubMed ID: 24945350
[TBL] [Abstract][Full Text] [Related]
20. Unaltered influenza disease outcomes in swine prophylactically treated with α-galactosylceramide.
Gu W; Madrid DMD; Yang G; Artiaga BL; Loeb JC; Castleman WL; Richt JA; Lednicky JA; Driver JP
Dev Comp Immunol; 2021 Jan; 114():103843. PubMed ID: 32871161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
